ArticleFrontiers in pharmacology2020

Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives.

Cheng-Wei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.